Consumer Services

JCDecaux SE
Société Européenne à Directoire et Conseil de Surveillance
Au capital de 3.264.372,84 €
Siège Social : 17, rue Soyer - 92200 Neuilly-sur-Seine (France)
307 570 747 RCS Nanterre

SkiStar AB will publish the Interim Report for the period 1 September 2024 – 31 May 2025 on Thursday 19 June 2025 at 07.00 a.m. CEST. In connection with the report SkiStar will organize a conference call with web presentation. CEO Stefan Sjöstrand and CFO Sara J Uggelberg will present and comment on the report. After the presentation there will be time for questions, both by phone and by chat in the web presentation. The presentation will be held in English.

SkiStar AB offentliggör sin delårsrapport för perioden 1 september 2024 – 31 maj 2025 torsdagen den 19 juni 2025 klockan 07.00 CEST. I samband med rapporten håller SkiStar en webbsänd presentation och telefonkonferens. Verkställande direktör Stefan Sjöstrand och ekonomi- och finansdirektör Sara J Uggelberg presenterar och kommenterar rapporten. Efter presentationen kommer det att finnas möjlighet att ställa frågor via telefon eller chatt i webbsändningen. Presentationen hålls på engelska.

Leuven, Belgium, June 12, 2025 – AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary Launch-iT technology, announced today the appointment of Dieter Weinand as Chair of the Board of Directors, effective June 12, 2025. Mr. Weinand is the former Chief Executive Officer of Bayer Pharma AG with more than 25 years of experience as a senior business leader in the pharmaceutical industry. He takes over from Dr. Jeanne Bolger, who served as Chair since 2022 and will remain on the Board as a non-executive independent director.

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against BigBear.ai Holdings, Inc. (NYSE:BBAI) on behalf of long-term stockholders following a class action complaint that was filed against BigBear on April 11, 2025 with a Class Period from March 31, 2022 through March 25, 2025. Our investigation concerns whether the board of directors of BigBear have breached their fiduciary duties to the company.

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against PepGen, Inc. (“PepGen” or the “Company”) (NASDAQ: PEPG) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired PepGen securities between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”). Investors have until August 8, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.